Essential PTX3 biology (not only) for cardiologists and cardiac surgeons

Pavel Kunes1, Vladimír Lonský, Jirí Mand'ák

  • 1Charles University in Prague, Faculty of Medicine in Hradec Králové, Department of Cardiac Surgery, Czech Republic. kunes.pavel@fnhk.cz

Acta Medica (Hradec Kralove)
|July 28, 2007
PubMed

Insights

Inflammation is key in atherosclerosis. Pentraxin 3 (PTX3), an acute phase reactant, may actively mediate cardiovascular diseases and wound healing, impacting innate immunity.

Area of Science:

  • Biochemistry
  • Immunology
  • Cardiology
  • Surgery

Background:

  • Inflammation is integral to atherosclerosis.
  • C-reactive protein (CRP) is a known mediator.
  • Pentraxin 3 (PTX3) is a newly identified acute phase reactant.

Purpose of the Study:

  • To review PTX3 biology in inflammation and innate immunity.
  • To discuss PTX3's role in cardiovascular disease from a cardiologist's view.
  • To examine PTX3's role in wound healing and infection from a surgeon's view.

Main Methods:

  • Literature review of recent scientific information.
  • Analysis of PTX3's structural and functional properties.
  • Comparison of PTX3 with CRP.

Main Results:

  • PTX3 shares properties with CRP but has unique biological functions.
  • PTX3 may play a role in cardiovascular disease pathogenesis.
  • PTX3 is involved in processes accompanying surgical wound healing and bacterial infections.

Conclusions:

  • PTX3 is a significant factor in inflammation and innate immunity.
  • PTX3's role in cardiovascular events and surgical complications warrants further investigation.
  • Understanding PTX3 biology offers insights for both cardiology and surgery.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...